Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 40.49 % in the past year, decrease in net sales/revenue by -18.51 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -160.11 %, Marginal decrease of -115.35% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Brooks Laboratories Limited. Notable increase of 123.45 % in net profit Year to Year, Brooks Laboratories Limited’s profitability increased by 147.64 % in this quarter.
- EPS over the Year and quarter: EPS increased by 116.67 % Year to Year. EPS increased by 149.67 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 12.614 Cr | Rs. 21.747 Cr | Rs. 17.722 Cr | -18.51 % | + 40.49 % |
| Expenses | Rs. 12.74 Cr | Rs. 20.65 Cr | Rs. 17.35 Cr | -15.98 % | + 36.19 % |
| Operating Profit | Rs. -0.13 Cr | Rs. 1.1 Cr | Rs. 0.37 Cr | -66.36 % | + 384.62 % |
| OPM % | -1.03 % | 5.06 % | 2.09 % | -2.97 % | + 3.12 % |
| Other Income | Rs. -3.56 Cr | Rs. -4.3 Cr | Rs. -9.26 Cr | -115.35 % | -160.11 % |
| Interest | Rs. 0.18 Cr | Rs. 0.21 Cr | Rs. 0.27 Cr | + 28.57 % | + 50 % |
| Depreciation | Rs. 0.44 Cr | Rs. 0.44 Cr | Rs. 0.46 Cr | + 4.55 % | + 4.55 % |
| Profit before tax | Rs. -4.31 Cr | Rs. -3.85 Cr | Rs. -9.62 Cr | -149.87 % | -123.2 % |
| Tax % | -0 % | 4.3 % | 0 % | -4.3 % | 0 % |
| Net Profit | Rs. -4.3 Cr | Rs. -3.88 Cr | Rs. -9.61 Cr | -147.68 % | -123.49 % |
| EPS in Rs | Rs. -1.74 | Rs. -1.51 | Rs. -3.77 | -149.67 % | -116.67 % |
Today, we’re looking at Brooks Laboratories Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 40.49 %. However, it did see a marginal slip of -18.51 % from the previous quarter. Expenses decreased slightly by -15.98 % quarter-on-quarter, aligning with the annual rise of 36.19 %. Operating profit, while up 384.62 % compared to last year, faced a quarter-on-quarter dip of -66.36 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 3.12 %, but a shrinkage of -2.97 % sequentially. Other income fell by -115.35 % compared to the last quarter, despite an annual decline of -160.11 %. Interest expenses surged remarkably by 28.57 % from the previous quarter, yet the year-over-year increase remains at a moderate 50 %. Depreciation costs climbed by 4.55 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 4.55 %. Profit before tax declined annually by -123.2 % but saw a reduction from the preceding quarter by -149.87 %.
with a more notable quarter-on-quarter decrease of -4.3 %. Net profit fell by -123.49 % year-on-year but witnessed a -147.68 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -116.67 % but a quarterly fall of -149.67 %. In summary, Brooks Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 12.614 Cr | Rs. 21.747 Cr | Rs. 17.722 Cr | -18.51 % | + 40.49 % |
| Expenses | Rs. 12.74 Cr | Rs. 20.65 Cr | Rs. 17.35 Cr | -15.98 % | + 36.19 % |
| Operating Profit | Rs. -0.13 Cr | Rs. 1.1 Cr | Rs. 0.37 Cr | -66.36 % | + 384.62 % |
| Net Profit | Rs. -4.3 Cr | Rs. -3.88 Cr | Rs. -9.61 Cr | -147.68 % | -123.49 % |
| EPS in Rs | Rs. -1.74 | Rs. -1.51 | Rs. -3.77 | -149.67 % | -116.67 % |
In reviewing Brooks Laboratories Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 40.49 % year-on-year growth, although there was a slight dip of -18.51 % from the previous quarter. Expenses rose by 36.19 % compared to the previous year, with a decrease of -15.98 % quarter-on-quarter. Operating Profit surged by 384.62 % annually, and saw a -66.36 % decrease from the last quarter.
Net Profit showed yearly decrease of -123.49 %, and experienced a -147.68 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -116.67 % annually, however dipped by -149.67 % compared to the last quarter. In essence, while Brooks Laboratories Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
